Tag Spinoffs
UW biotech spinoff Mirus Bio celebrates two decades in business
The company makes cutting-edge products based on discoveries by three UW scientists for delivering DNA and RNA into cells.
Cancer treatment spinoff takes top honor in life science at Governor’s Business Plan Contest
Lynx Biosciences is developing technology to choose the drug most likely to benefit a blood cancer patient by analyzing how the tumor cells respond.
Five UW spinoffs among finalists in Governor’s Business Plan Contest
The contestants emerged from about 200 entries and three rounds of judging in the contest organized by the Wisconsin Technology Council.
UW tech spinoff promises to rethink design with ultra-fast software
Everything changes if you can figure out a way to keep a "hungry" computer processor fed.
UW technology key to growth as firm stays in Madison long after sale
The explosion in next-generation sequencing has opened windows throughout medicine and biology.
Brenner’s simpler fertility test is basis for promising UW–Madison spinoff
BluDiagnostics co-founder Katie Brenner says the idea came directly from her own difficulty with conception.
Madison-made electrolyte going big at global battery manufacturer
Silatronix, a UW–Madison spinoff, says its formulation will lead to safer lithium-ion batteries used in phones, laptops and tablets.
UW spinoff tracks weightlifter safety, performance
WeightUp is a unique weightlifter monitoring system that not only counts reps, but also can detect sloppy form that can undermine the benefits of lifting.
Autism test on the horizon as firm screens for signatures of disorder
Early diagnosis for autism can allow quicker, better treatment. In the best case, it could pinpoint ways to reduce the symptoms or even prevent the disorder.
UW-Madison spinoff receives construction permit for medical isotope plant in Janesville
This is the first time since 1961 that the NRC has issued a permit for a facility to make the life-saving isotopes.
Small-scale protein production a big business for UW spinoff
Unlike many young biotech spinoffs, Fritz Schomburg's company — Lytic — earns its income not from federal research grants, but from shipping product.